Cargando…
Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia
BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not exclu...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405483/ https://www.ncbi.nlm.nih.gov/pubmed/37550778 http://dx.doi.org/10.1186/s13195-023-01280-z |
_version_ | 1785085541465718784 |
---|---|
author | Azami, Hamed Zrenner, Christoph Brooks, Heather Zomorrodi, Reza Blumberger, Daniel M. Fischer, Corinne E. Flint, Alastair Herrmann, Nathan Kumar, Sanjeev Lanctôt, Krista Mah, Linda Mulsant, Benoit H. Pollock, Bruce G. Rajji, Tarek K. |
author_facet | Azami, Hamed Zrenner, Christoph Brooks, Heather Zomorrodi, Reza Blumberger, Daniel M. Fischer, Corinne E. Flint, Alastair Herrmann, Nathan Kumar, Sanjeev Lanctôt, Krista Mah, Linda Mulsant, Benoit H. Pollock, Bruce G. Rajji, Tarek K. |
author_sort | Azami, Hamed |
collection | PubMed |
description | BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not excluding the EEG aperiodic components, which are less associated with cognition than the periodic components. Here, we investigate whether aperiodic and periodic EEG components are disrupted differently in AD or MCI vs. healthy control (HC) individuals and whether a periodic based beta/theta ratio differentiates better MCI from AD and HC groups than a ratio based on the full spectrum. METHODS: Data were collected from 44 HC (mean age (SD) = 69.1 (5.3)), 114 MCI (mean age (SD) = 72.2 (7.5)), and 41 AD (mean age (SD) = 75.7 (6.5)) participants. Aperiodic and periodic components and full spectrum EEG were compared among the three groups. Receiver operating characteristic curves obtained via logistic regression classifications were used to distinguish the groups. Last, we explored the relationships between cognitive performance and the beta/theta ratios based on the full or periodic spectrum. RESULTS: Aperiodic EEG components did not differ among the three groups. In contrast, AD participants showed an increase in full spectrum and periodic relative powers for delta, theta, and gamma and a decrease for beta when compared to HC or MCI participants. As predicted, MCI group differed from HC participants on the periodic based beta/theta ratio (Bonferroni corrected p-value = 0.036) measured over the occipital region. Classifiers based on beta/theta power ratio in EEG periodic components distinguished AD from HC and MCI participants, and outperformed classifiers based on beta/theta power ratio in full spectrum EEG. Beta/theta ratios were comparable in their association with cognition. CONCLUSIONS: In contrast to a full spectrum EEG analysis, a periodic-based analysis shows that MCI individuals are different on beta/theta ratio when compared to healthy individuals. Focusing on periodic components in EEG studies with or without other biological markers of neurodegenerative diseases could result in more reliable findings to separate MCI from healthy aging, which would be valuable for designing preventative interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01280-z. |
format | Online Article Text |
id | pubmed-10405483 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104054832023-08-08 Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia Azami, Hamed Zrenner, Christoph Brooks, Heather Zomorrodi, Reza Blumberger, Daniel M. Fischer, Corinne E. Flint, Alastair Herrmann, Nathan Kumar, Sanjeev Lanctôt, Krista Mah, Linda Mulsant, Benoit H. Pollock, Bruce G. Rajji, Tarek K. Alzheimers Res Ther Research BACKGROUND: Alzheimer’s dementia (AD) is associated with electroencephalography (EEG) abnormalities including in the power ratio of beta to theta frequencies. EEG studies in mild cognitive impairment (MCI) have been less consistent in identifying such abnormalities. One potential reason is not excluding the EEG aperiodic components, which are less associated with cognition than the periodic components. Here, we investigate whether aperiodic and periodic EEG components are disrupted differently in AD or MCI vs. healthy control (HC) individuals and whether a periodic based beta/theta ratio differentiates better MCI from AD and HC groups than a ratio based on the full spectrum. METHODS: Data were collected from 44 HC (mean age (SD) = 69.1 (5.3)), 114 MCI (mean age (SD) = 72.2 (7.5)), and 41 AD (mean age (SD) = 75.7 (6.5)) participants. Aperiodic and periodic components and full spectrum EEG were compared among the three groups. Receiver operating characteristic curves obtained via logistic regression classifications were used to distinguish the groups. Last, we explored the relationships between cognitive performance and the beta/theta ratios based on the full or periodic spectrum. RESULTS: Aperiodic EEG components did not differ among the three groups. In contrast, AD participants showed an increase in full spectrum and periodic relative powers for delta, theta, and gamma and a decrease for beta when compared to HC or MCI participants. As predicted, MCI group differed from HC participants on the periodic based beta/theta ratio (Bonferroni corrected p-value = 0.036) measured over the occipital region. Classifiers based on beta/theta power ratio in EEG periodic components distinguished AD from HC and MCI participants, and outperformed classifiers based on beta/theta power ratio in full spectrum EEG. Beta/theta ratios were comparable in their association with cognition. CONCLUSIONS: In contrast to a full spectrum EEG analysis, a periodic-based analysis shows that MCI individuals are different on beta/theta ratio when compared to healthy individuals. Focusing on periodic components in EEG studies with or without other biological markers of neurodegenerative diseases could result in more reliable findings to separate MCI from healthy aging, which would be valuable for designing preventative interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01280-z. BioMed Central 2023-08-07 /pmc/articles/PMC10405483/ /pubmed/37550778 http://dx.doi.org/10.1186/s13195-023-01280-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Azami, Hamed Zrenner, Christoph Brooks, Heather Zomorrodi, Reza Blumberger, Daniel M. Fischer, Corinne E. Flint, Alastair Herrmann, Nathan Kumar, Sanjeev Lanctôt, Krista Mah, Linda Mulsant, Benoit H. Pollock, Bruce G. Rajji, Tarek K. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title | Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title_full | Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title_fullStr | Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title_full_unstemmed | Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title_short | Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia |
title_sort | beta to theta power ratio in eeg periodic components as a potential biomarker in mild cognitive impairment and alzheimer’s dementia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405483/ https://www.ncbi.nlm.nih.gov/pubmed/37550778 http://dx.doi.org/10.1186/s13195-023-01280-z |
work_keys_str_mv | AT azamihamed betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT zrennerchristoph betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT brooksheather betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT zomorrodireza betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT blumbergerdanielm betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT fischercorinnee betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT flintalastair betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT herrmannnathan betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT kumarsanjeev betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT lanctotkrista betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT mahlinda betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT mulsantbenoith betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT pollockbruceg betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT rajjitarekk betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia AT betatothetapowerratioineegperiodiccomponentsasapotentialbiomarkerinmildcognitiveimpairmentandalzheimersdementia |